• Thu, June 18, 2015
  • Mon, June 22, 2015
  • Fri, June 19, 2015
  • Tue, June 23, 2015
  • Wed, June 24, 2015

David Amsellem Maintained (SUPN) at Buy with Increased Target to $20 on, Jun 18th, 2015

David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Increased Target from $16 to $20 on, Jun 18th, 2015.

David, nor any peers, have made any analyst calls on SUPN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍